Literature DB >> 12722166

Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.

Aurélie Funkiewiez1, Claire Ardouin, Paul Krack, Valérie Fraix, Nadège Van Blercom, Jing Xie, Elena Moro, Alim-Louis Benabid, Pierre Pollak.   

Abstract

High-frequency deep brain stimulation (DBS) of the subthalamic nucleus (STN) improves the motor symptoms of Parkinson's disease (PD). Opposite changes in mood, such as mania or depression, have been reported after surgery, but it is not known whether these side effects are specifically related to STN DBS. To learn whether STN DBS also influences the limbic loop, we investigated acute subjective psychotropic effects related to levodopa or bilateral STN DBS. After a median postoperative follow-up of 12 months, 50 PD patients completed the Addiction Research Center Inventory (ARCI), assessing subjective psychotropic effects in four conditions: off-drug/on-stimulation; off-drug/off-stimulation; on-drug/off-stimulation; and on-drug/on-stimulation. Both levodopa and STN DBS improved all the ARCI subscales, indicating subjective feelings of well being, euphoria, increase in motivation, and decrease in fatigue, anxiety, and tension. A suprathreshold dose of levodopa was significantly more effective than STN DBS, using the same electrical parameters as for chronic stimulation, on four of the five ARCI subscales. We concluded that 1) both STN DBS and levodopa have synergistic acute beneficial psychotropic effects in PD, 2) the psychotropic effects of both treatments need to be considered in the long-term management of chronic STN DBS, and 3) the results indicate an involvement of the limbic STN in mood disorders of PD. Copyright 2003 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12722166     DOI: 10.1002/mds.10441

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  52 in total

1.  Specific treatment of residual fatigue in depressed patients.

Authors:  Humberto Marin; Matthew A Menza
Journal:  Psychiatry (Edgmont)       Date:  2004-09

2.  Deep brain stimulation in Parkinson's disease.

Authors:  S J Groiss; L Wojtecki; M Südmeyer; A Schnitzler
Journal:  Ther Adv Neurol Disord       Date:  2009-11       Impact factor: 6.570

3.  Motor and non motor effects during intraoperative subthalamic stimulation for Parkinson's disease.

Authors:  Paul Sauleau; Sylvie Raoul; François Lallement; Isabelle Rivier; Sophie Drapier; Youenn Lajat; Marc Verin
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

4.  Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease?

Authors:  V Czernecki; B Pillon; J L Houeto; M L Welter; V Mesnage; Y Agid; B Dubois
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-06       Impact factor: 10.154

5.  Influence of bilateral Stn-stimulation on psychiatric symptoms and psychosocial functioning in patients with Parkinson's disease.

Authors:  K Kalteis; H Standhardt; I Kryspin-Exner; T Brücke; D Volc; F Alesch
Journal:  J Neural Transm (Vienna)       Date:  2005-12-16       Impact factor: 3.575

6.  Change in artistic expression related to subthalamic stimulation.

Authors:  K Witt; P Krack; G Deuschl
Journal:  J Neurol       Date:  2006-04-20       Impact factor: 4.849

7.  Depression and intelligence in patients with Parkinson's disease and deep-brain stimulation.

Authors:  Courtney R Schadt; Katie L Cox; Michael G Tramontana; Daniel W Byrne; Thomas L Davis; John Y Fang; Peter E Konrad; Bhavna Padaliya; Robert W Mutter; Chandler E Gill; Caralee R Richardson; P David Charles
Journal:  J Natl Med Assoc       Date:  2006-07       Impact factor: 1.798

8.  High frequency stimulation of the subthalamic nucleus modulates neurotransmission in limbic brain regions of the rat.

Authors:  Christine Winter; Christoph Lemke; Reinhard Sohr; Wassilios Meissner; Daniel Harnack; Georg Juckel; Rudolf Morgenstern; Andreas Kupsch
Journal:  Exp Brain Res       Date:  2007-10-26       Impact factor: 1.972

9.  Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus.

Authors:  D De Gaspari; C Siri; A Landi; R Cilia; A Bonetti; F Natuzzi; L Morgante; C B Mariani; E Sganzerla; G Pezzoli; A Antonini
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

Review 10.  Mechanisms and targets of deep brain stimulation in movement disorders.

Authors:  Matthew D Johnson; Svjetlana Miocinovic; Cameron C McIntyre; Jerrold L Vitek
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.